» Articles » PMID: 30356368

Formula Inhibits Pancreatic Cell Apoptosis in Type 2 Diabetes Mellitus Via MEK-ERK-Caspase-3 Signaling Pathway

Overview
Date 2018 Oct 26
PMID 30356368
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: formula (WSZYF), composed of , , , and , is effective in the treatment of type 2 diabetes mellitus (T2DM).

Aim: In this study, we aimed to explore the effects and the underlying mechanisms of WSZYF on inhibiting pancreatic cell apoptosis and improving insulin resistance (IR) in T2DM.

Methods: A T2DM model was induced by Goto-Kakizaki diabetes prone rats. Cell apoptosis model was induced in MIN6 cells.

Results: , WSZYF decreased fasting blood glucose (FBG), insulin concentration, insulin resistance index, triglyceride (TG), total cholesterol (TC), and free fatty acids (FFA) in T2DM rats. Meanwhile, WSZYF ameliorated impairments in the morphology and structure of pancreatic tissues. , WSZYF enhanced cell viability and promoted insulin secretion in the apoptosis model of MIN6 cells. Furthermore, WSZYF modulated the expressions of apoptosis-related molecules by increasing the expressions of MEK1/2, p-MEK1/2, ERK1/2, and p-ERK1/2 and decreasing the cleaved-caspase-3 expression.

Conclusion: These findings indicate that WSZYF may become a new drug candidate in the treatment of T2DM and its antidiabetic mechanism is probably inhibiting pancreatic cell apoptosis by modulating the MEK-ERK-Caspase-3 signaling pathway.

Citing Articles

Glucosamine substituted sulfonylureas: IRS-PI3K-PKC-AKT-GLUT4 insulin signalling pathway intriguing agent.

Suaifan G, Alkhawaja B, Shehadeh M, Sharmaa M, Hor Kuan C, Okechukwu P RSC Med Chem. 2024; 15(2):695-703.

PMID: 38389876 PMC: 10880904. DOI: 10.1039/d3md00647f.


Total saponins can reverse type 2 diabetes mellitus-related intestinal dysbiosis and hepatic insulin resistance .

Ma L, La X, Zhang B, Xu W, Tian C, Fu Q Front Endocrinol (Lausanne). 2023; 14:1190827.

PMID: 38053727 PMC: 10694298. DOI: 10.3389/fendo.2023.1190827.


Prevention of Oxidative Stress-Induced Pancreatic Beta Cell Damage by Siebold Fruit Extract Via the ERK-Nox4 Pathway.

Kim H, Kim D, Yoon H, Choi C, Oh Y, Jun H Antioxidants (Basel). 2020; 9(5).

PMID: 32397640 PMC: 7278704. DOI: 10.3390/antiox9050406.


Ameliorative Effect and Mechanism of the Purified Anthraquinone-Glycoside Preparation from L. on Type 2 Diabetes Mellitus.

Cheng F, Cui H, Fang J, Yuan K, Guo Y Molecules. 2019; 24(8).

PMID: 31013790 PMC: 6515271. DOI: 10.3390/molecules24081454.

References
1.
Cao M, Lu X, Liu G, Su Y, Li Y, Zhou J . Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1. Exp Ther Med. 2018; 15(1):576-584. PMC: 5769236. DOI: 10.3892/etm.2017.5400. View

2.
Horiuchi Y, Nakatsu D, Kano F, Murata M . Pyruvate kinase M1 interacts with A-Raf and inhibits endoplasmic reticulum stress-induced apoptosis by activating MEK1/ERK pathway in mouse insulinoma cells. Cell Signal. 2017; 38:212-222. DOI: 10.1016/j.cellsig.2017.07.017. View

3.
Martinez-Moreno J, Garciacaballero M . Influences of the diabetes surgery on pancreatic β-cells mass. Nutr Hosp. 2013; 28 Suppl 2:88-94. DOI: 10.3305/nh.2013.28.sup2.6718. View

4.
Hu G, Zhang J, Xu F, Deng H, Zhang W, Kang S . Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells. Cancer Sci. 2018; 109(5):1357-1368. PMC: 5980381. DOI: 10.1111/cas.13563. View

5.
Lorenzo C, Wagenknecht L, DAgostino Jr R, Rewers M, Karter A, Haffner S . Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2009; 33(1):67-72. PMC: 2797988. DOI: 10.2337/dc09-1115. View